WORK Medical Technology Group LTD

The grade, in three tenses

Headline 3.9 out of ten, 8 of 9 metrics filed and 1 estimated: past 3.3 out of ten, present 3.9 out of ten, future 4.6 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.

The nine metrics

• Surviving crises (past): 5.5 out of ten. 1 warning event since 2022; the latest 2025-01-31. 55th percentile among 121 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Track record (past): 2.4 out of ten. -20.6% a year over 4 filed years; profitable in 2 of 4. 24th percentile among 105 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Shareholder treatment (past): 1.8 out of ten. Share count grew 32.3% a year. 0% of cash flow returned. Insiders: 0 sales, 0 purchases. 18th percentile among 40 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Financial health (present): 4.0 out of ten. ROE -5%: lost 5¢ per shareholder dollar. Leverage 36%: owes 36¢ per asset dollar. 40th percentile among 120 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Industry position (present): 3.0 out of ten. bottom 30% of 109 in its family; net margin -10.9%. 30th percentile among 109 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Leadership (present): 5.0 out of ten. CrossAssetData estimate 5.0/10, confidence 20 of 100 (family median). 50th percentile among 105 sector filers. A CrossAssetData estimate, not a filed reading: family median, confidence 20 of 100; its next annual report on file with the inputs replaces this estimate with the filed reading.
• Room to expand (future): 4.5 out of ten. bottom 45% of 104 in its family for room to expand. 45th percentile among 104 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Growth drivers (future): 4.7 out of ten. bottom 47% of 105 in its family for growth drivers. 47th percentile among 105 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
• Expectations vs reality (future): 4.3 out of ten. bottom 43% of 88 in its family for expectations against reality. 43rd percentile among 88 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).

The filing record

Newest annual report: Form 20-F filed 2026-01-30 for the period ended 2025-09-30 (on EDGAR). Newest filing: Form 6-K, 2026-08-24. Filings on record since 2022. Read from EDGAR 2026-10-12.

Who runs it

Wu, Shuang Jarod (CEO and Director); Liang, Ningfang (Chief Financial Officer); Yu, Baiming (COO and Director); Johnson, Robert Brian (director); Lin, Qisheng (director); Wu, Zhenguo (director). 6 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.

This file: Overview · Past · Present · Future · Filings · every company on file

Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.